In a clinical trial, PCDH8 was inhibited in tumor tissues when compared with that in non-tumor tissues, particularly in patients with advanced hypopharyngeal carcinoma, suggesting that PCDH8 could be a prognostic biomarker and target for the treatment of this type of cancer 29. The gene discussed is PCDH8; the disease is hypopharyngeal carcinoma.